about
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycleAn anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation.IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.CXC chemokines and antimicrobial peptides in rhinovirus-induced experimental asthma exacerbations.Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis.Anti-inflammatory effect of fullerene C60 in a mice model of atopic dermatitis.Pathophysiological mechanisms of exercise-induced anaphylaxis: an EAACI position statement.Antiviral Activity of Ergoferon against Group A Rotavirus.Synthesis and evaluation of novel lipopeptide as a vehicle for efficient gene delivery and gene silencing.Interleukins 1 and 6 as Main Mediators of Inflammation and Cancer.Molecular aspects of allergens in atopic dermatitisThe potential of anti-infectives and immunomodulators as therapies for asthma and asthma exacerbations.Rhinovirus induction of fractalkine (CX3CL1) in airway and peripheral blood mononuclear cells in asthma.Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results.Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).RSV infection modulates IL-15 production and MICA levels in respiratory epithelial cells.Gene Editing in Human Lymphoid Cells: Role for Donor DNA, Type of Genomic Nuclease and Cell Selection Method.Influenza burden, prevention, and treatment in asthma-A scoping review by the EAACI Influenza in asthma task force.[Lactose-based glycoconjugates with variable spacers for design of liver-targeted liposomes].[Physicochemical properties of lipopeptide-based liposomes and their complexes with siRNA].[Anticytokine therapy of allergic asthma].Effects of Release-Active Antibodies to CD4 Receptor on the Level of lck-Kinase in Cultured Mononuclear Cells from Human Peripheral Blood.Microarray-based IgE serology improves management of severe atopic dermatitis in two children.Effect of lipopeptide structure on gene delivery system properties: Evaluation in 2D and 3D in vitro models.Molecular Aspects of Allergens and Allergy.Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches.Differences in Reporting the Ragweed Pollen Season Using Google Trends across 15 CountriesAllergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?Cross-sectional study on Asthma Insights and Management in the Gulf and RussiaA novel peptide dendrimer LTP efficiently facilitates transfection of mammalian cellsDetermination of IgE and IgG reactivity to more than 170 allergen molecules in paper-dried blood spotsAllergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses[Anti-peptide antibodies specifically recognize the L1 protein of human papilloma virus type 31]Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal CancerMolecular Approaches for Diagnosis, Therapy and Prevention of Cow´s Milk AllergyRecombinant allergens for immunotherapy: state of the artBet v 1-specific IgE levels and PR-10 reactivity discriminate silent sensitization from phenotypes of birch allergyExperimental protocol for development of adjuvant-free murine chronic model of allergic asthmaRetraction notice to "Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results" [Antiviral Research 142 (2017) 185-192]Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms
P50
Q28355722-45294F11-B235-40B6-BEC9-9E481B2C42C1Q34916830-CF854BF1-A5A4-4C00-8196-6E958C762E1EQ34987195-825A5062-FC35-49B2-98BE-4C43027BE773Q35495112-42ACBF00-78A0-4B6C-A286-739C3D82C996Q35746514-F29AE37F-822D-48C2-9CF9-F21F67F16CA9Q36503446-110C344E-4529-460C-B52B-5A2D22C002D3Q38534844-E514CFAA-FE17-476C-B42D-077483153DA0Q38736694-3A3696D3-6E69-4A87-A82E-1EFA808C7F68Q38785064-93D2D979-A3E0-4B87-9B7C-4CD0578C6BF9Q38853516-8F4E4777-7AE2-4F27-91F6-6952B7B2FE5AQ39378515-DED35088-6EC3-4185-A0C5-A5D25084A95AQ39444008-1BA0147C-5259-4BF9-99FC-052B538C2521Q40062909-0148B59F-AD94-4A5F-A2A1-27E0BFDC8084Q40268153-661FE0D3-D136-4C2F-9929-F5765AC84D97Q42320566-95B10B5A-17ED-4CF5-885F-7E3B627F55E8Q44338651-4EBD0DF4-A549-438B-8FB5-2FC016E8084DQ47161361-BD330877-27C0-4924-B379-37BD961C08F1Q47589915-CB9EC0B7-396B-4D75-B179-D2EA6DD80481Q50101620-DB0ACDCD-AEF2-46ED-A8BD-01A2AC9A6F83Q50101624-2607718C-9EDA-4555-B8D6-0B16208B30B0Q50865860-4376D151-E99E-4AE0-9549-275C7255A65EQ51188773-ABDA714B-0574-4D78-9CD2-750A6087E57AQ51536286-9E5A0148-BC87-4E97-B571-5EF49DB3E16AQ52569431-6B6AB8A8-2D0B-4AC0-BFD1-FBD6AC8B808AQ53825271-1019E2AE-840F-42E7-BC0D-C7F78C81E2FAQ55436442-F103B8B1-E0DE-4223-81A3-AB0BC2A3EBC9Q56957393-8A6AF5A6-7C63-4A7A-96EE-485670185017Q57297464-AD9FB926-0B9A-4438-B3A2-9457CC3EB64EQ57455359-5E89E907-2899-43B7-A092-77D99C525549Q57793898-81E9A713-6CED-4511-9326-747601178933Q58543987-4C4AED95-87FE-4B3A-B88C-ACF970132F39Q61814280-F123CB87-D526-4AF4-99F9-F6AB87508883Q86520636-1752B627-F639-4A04-A118-78270755FFD3Q91076464-F1E4B55C-21B3-4C05-AD63-48416190E1A0Q91520272-C8DFD21B-248B-488D-85EB-93A6235F5B85Q91977713-279C395D-6258-4FD9-AAC1-672102D81A11Q92402195-1597651F-3DCC-47EF-9C43-5083CCAFF4E2Q92422103-4E3FDA30-1279-4CB3-9E90-37056357F89AQ92454275-4BB982EF-5BAC-4969-8BF1-E978F94EAAF6Q93339707-327E1D9D-88E6-4AFA-847F-626799D397D0